Rainbow Coral Corp. (OTCQB:RBCC) President and CEO Kimberly Palmer issued the following open letter to stockholders today, reviewing the Company’s 2015 achievements and providing a peek at what’s to come in 2016:

Dear Stockholders,

RBCC has just concluded a very successful and memorable calendar year that saw our company make tremendous strides towards advancing and achieving our strategic goals. Today I want to review with you, our valued shareholders, several of our benchmark accomplishments and give you a peek ahead as to what we have planned for the coming 12 months.

Our Progress in the Fight Against Addiction

RBCC moved steadily forward in 2015 in the ongoing battle against alcohol and opioid abuse and addiction. With the year closed, we can look back on a number of important advances, including our work towards opening a Canadian front in these battles. RBCC engaged in several talks with Canadian pharmaceutical, medical and ethnic wellness organizations about the solutions RBCC can provide to their groups to ensure alcohol and opioid abuse and addiction are not only controlled, but eventually eradicated.

In the U.S., our company has made concentrated efforts to inaugurate affordable, inclusive alcohol and opioid abuse treatment programs, giving hope to people who truly need help but who can’t afford the expensive facilities that currently exist.

We Remain Focused on Personalized Medicine

RBCC is currently pursuing several exciting opportunities in personalized medicine. First among these are a number of innovative products geared to the pharmaceutical compounding industry. In addition, we continue our work with adult stem cells as we believe a variety of important treatments can be derived from such research, reprogramming a patient’s own existing cells to more effectively fight diseases. We also remain committed to developing new topical and injectable drug protocols we believe offer great promise. With our partners, we also continue to explore and innovate in the revolutionary world of bioprinting, an area that could forever alter the world of medicine in ways once considered only science fiction.

Our Plans for the Year Ahead

Recent news reports talk about the tremendous and record-setting amount of venture capital now pouring into the medical and healthcare industry. Investors are now realizing that not only can this area provide many beneficial products and services to help people in need, it can also offer substantial potential future returns on investments. We believe this validates our business plan and shows that we were ahead of the curve with our long-range strategy.

As we pass into a new year, RBCC plans to seek out additional partners and capital to help us continue and expand our success in the worlds of addiction treatment and personalized medicine. The Company looks to make forward strides on our addiction treatment program and expects continued progress on the work we began last year in Canada. Finally, we are confident we will make further progress in bioprinting with greater distribution worldwide.

In closing, I want to thank you for your support and faith in the Company and its plan. This past year was one of tremendous progress and I believe 2016 holds even brighter things ahead. The best is yet to come.

Warmest Regards,

Kimberly Palmer — President and CEO, Rainbow Coral Corp.

About Rainbow Biosciences

Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (RBCC). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit www.RainbowBioSciences.com. For investment information and performance data on the Company, please visit www.RainbowBioSciences.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.